BCRX
BioCryst Pharmaceuticals, Inc. · Healthcare
President and CEO Jon P Stonehouse sold $2.8M of BioCryst Pharmaceuticals, Inc.
Sold$2,767,360
$15.04Price
184,000Shares
−17%Stake
What BCRX did after the filing
- The stock from Thu, Jan 13 close, $16.15
- +2.8%
- S&P 500, same days
- −6.0%
Measured over 30 trading days, to the Feb 28 close.
Traded Tue, Jan 11. Filed Thu, Jan 13, 11:45 AM ET, during the session. Returns use the Jan 13 close and the Feb 28 close. Not investment advice.